Net Loss Per Common Share
Nine Months Ended September 30, | |||||||||||
Shares issuable upon: | 2021 | 2020 | |||||||||
(unaudited) | |||||||||||
Conversion of Series A Common Equivalent Preferred Stock | 6,665,841 | — | |||||||||
Exercise of stock options | 3,961,959 | 3,416,345 | |||||||||
Exercise of common stock warrants | 797,487 | 956,552 | |||||||||
Vesting of PSUs and RSUs | 861,638 | 496,592 | |||||||||
Total | 12,286,925 | 4,869,489 |
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Acutus Medical, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - June 24, 2022
Acutus Medical, Inc. director just disposed of 60,000 shares - June 3, 2022
Acutus Medical, Inc.'s Chief Financial Officer just picked up 100,000 shares - June 2, 2022